Buzzing stocks: L&T, Oil India, Asian Paints, HDFC Bank, HDFC AMC, Godrej Consumer, McLeod Russel, Lehar Footwears, Cadila Healthcare, RVNL, Siemens, Sanofi India, Dr Lal Path Labs, AB Capital, CARE Rating, PTC India Fin, Eicher, Gillette, Religare

Stocks to watch today — May 11, 2023

Zydus Lifesciences rose 1.51% to Rs 380 after Cadila Healthcare, U.S. subsidiary of the company has received final approval from the USFDA to market Cariprazine capsules.

Zydus Life rises on USFDA nod for schizophrenia drug

The drug firm, earlier known as Cadila Healthcare, has fixed July 15, 2022 as the last date for the settlement of bids on stock exchanges which may even happen early, as per a regulatory filing.

Zydus Lifesciences’ Rs 750 cr-share buyback open between June 23-July 6

Cadila Healthcare has rebranded itself to Zydus Lifesciences after nearly three decades. In this episode of The Medicine Box, we speak with their Managing Partner Sharvil Patel to understand the way ahead for them with the new name holding some significance and the business and growth outlook.

#BusinessNews #BusinessNewsToday #BusinessNewsInEnglish #ShareMarketToday #SharvilPatel #ZydusLifesciences

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action: https://www.cnbctv18.com/market/stocks/live-blog

Follow experts on the most vital topics: https://www.cnbctv18.com/expert-views/

Subscribe to our daily newsletter: https://www.cnbctv18.com/newsletter/



Subscribe to our Channel: https://tinyurl.com/y6rvugay

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Sharvil Patel Discusses Zydus Lifesciences Rebranding & Biz Outlook | The Medicine Box | CNBC-TV18

Cadila Healthcare Chairman Pankaj Patel said the market can grow when there is overall growth

Domestic branded generic formulations market can grow at 10-12%: Industry

Zydus Lifesciences (earlier known as Cadila Healthcare) says Sentynl will make cash payments upon the achievement of certain regulatory milestones.

Zydus Lifesciences jumps over 5% after US arm buys global rights for BridgeBio’s Nulibry

The drug firm, formerly known as Cadila Healthcare, said it has received approval for its new drug application (NDA) the product.

Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease

Zydus Lifesciences on Monday said it has received an approval from the Drug Controller General of India (DCGI) for Oxemia (Desidustat), a first-of-its-kind oral treatment for anaemia associated with chronic kidney disease (CKD). The drug firm, formerly known as Cadila Healthcare, said it has receive…

Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease

Zydus Lifesciences gets DCGI nod for drug to treat anaemia associated with chronic kidney disease

Stocks in news: Linde India, Coal India, Vodafone Idea, InterGlobe Aviation, Bharat Forge, Cadila Healthcare, Minda Industries, KSB and more

Stocks in news: Coal India, Vodafone Idea, InterGlobe Aviation, Bharat Forge and more

Unveils ‘innovation and care’ centric corporate brand identity

Cadila Healthcare changes name to Zydus Lifesciences Limited

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Zydus Lifesciences Ltd is an India-based life sciences company. The Company has a pipeline for Biologics and Vaccines.